Asian Pacific Journal of Cancer Prevention

  • 제15권10호
  • /
  • Pages.4281-4287
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Assessment of the Prognostic Value of Methylation Status and Expression Levels of FHIT, GSTP1 and p16 in Non-Small Cell Lung Cancer in Egyptian Patients

  • 발행 : 2014.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Methylation of tumor suppressor genes has been investigated in all kinds of cancer. Tumor specific epigenetic alterations can be used as a molecular markers of malignancy, which can lead to better diagnosis, prognosis and therapy. Therefore, the aim of this study was to evaluate the association between gene hypermethylation and expression of fragile histidine triad (FHIT), glutathione S-transferase P1 (GSTP1) and p16 genes and various clinicopathologic characteristics in primary non-small cell lung carcinomas (NSCLC). Materials and Methods: The study included 28 primary non-small cell lung carcinomas, where an additional 28 tissue samples taken from apparently normal safety margin surrounding the tumors served as controls. Methylation-specific polymerase chain reaction (MSP) was performed to analyze the methylation status of FHIT, GSTP1 and p16 while their mRNA expression levels were measured using a real-time PCR assay with SYBR Green I. Results: The methylation frequencies of the genes tested in NSCLC specimens were 53.6% for FHIT, 25% for GSTP1, and 0% for p16, and the risk of FHIT hypermethylation increased among patients with NSCLC by 2.88, while the risk of GSTP1 hypermethylation increased by 2.33. Hypermethylation of FHIT gene showed a highly significant correlation with pathologic stage (p<0.01) and a significant correlation with smoking habit and FHIT mRNA expression level (p<0.05). In contrast, no correlation was observed between the methylation of GSTP1 or p16 and smoking habit or any other parameter investigated (p>0.05). Conclusions: Results of the present study suggest that methylation of FHIT is a useful biomarker of biologically aggressive disease in patients with NSCLC. FHIT methylation may play a role in lung cancer later metastatic stages while GSTP1 methylation may rather play a role in the early pathogenesis.

키워드

참고문헌

  1. Bhat IA, Pandith AA, Bhat BA, et al (2013). Lack of association of a common polymorphism in the 3' -UTR of interleukin 8 with non small cell lung cancer in Kashmir. Asian Pac J Cancer Prev, 14, 4403-8. https://doi.org/10.7314/APJCP.2013.14.7.4403
  2. Cantlay AM, Smith CA, Wallace WA, et al (1994). Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax, 49, 1010-4. https://doi.org/10.1136/thx.49.10.1010
  3. Cauchi S, Han W, Kumar SV, et al (2006). Haplotypeenvironment interactions that regulate the human glutathione S-transferase P1 promoter. Cancer Res, 66, 6439-48. https://doi.org/10.1158/0008-5472.CAN-05-4457
  4. Cecener G, Tunca B, Egeli U, et al (2008). Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer. Tumori, 94, 845-8.
  5. D'Agostini F, Izzotti A, Balansky R, et al (2006). Early loss of fhit in the respiratory tract of rodents exposed to environmental cigarette smoke. Cancer Res, 66, 3936-41. https://doi.org/10.1158/0008-5472.CAN-05-3666
  6. Geradts J, Fong KM, Zimmerman PV, et al (2000). Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features. Br J Cancer, 82, 1191-7. https://doi.org/10.1054/bjoc.1999.1062
  7. Han W, Pentecost BT, Pietropaolo RL, et al (2005). Estrogen receptor a increases basal and cigarette smoke extractinduced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog, 44, 202-11. https://doi.org/10.1002/mc.20128
  8. Henshall SM, Quinn DI, Lee CS, et al (2001). Overexpression of the Cell Cycle Inhibitor p16INK4A In High-grade Prostatic Intraepithelial Neoplasia Predicts Early Relapse in Prostate Cancer Patients. Clin Cancer Res, 7, 544-50.
  9. Herman JG, Graff JR, Myohanen S, et al (1996). Methylationspecific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 93, 9821-6. https://doi.org/10.1073/pnas.93.18.9821
  10. Ki KD, Lee SK, Tong SY, et al (2008). Role of 5'-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol, 19, 117-22. https://doi.org/10.3802/jgo.2008.19.2.117
  11. Kim JS, Kim H, Shim YM, et al (2004). Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis, l25, 2165-71. https://doi.org/10.1093/carcin/bgh217
  12. Li J, Poi MJ, Tsai MD (2011). Regulatory mechanisms of tumor suppressor P16INK4A and their relevance to cancer. Biochemistry, 50, 5566-82. https://doi.org/10.1021/bi200642e
  13. Li W, Deng J, Jiang P, et al (2010). Association of 5' CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese population. Cancer Biology & Therapy, 10, 997-1000. https://doi.org/10.4161/cbt.10.10.13231
  14. Lin J, Yao DM, Qian J, et al (2008). Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome. Leuk Res, 32, 1541-5. https://doi.org/10.1016/j.leukres.2008.02.008
  15. Liu Y-J, Lin Y-F, Chen Y-F, et al (2013). MicroRNA-449a Enhances Radiosensitivity in CL1-0 Lung Adenocarcinoma Cells. PLoS ONE, 8, 62383. https://doi.org/10.1371/journal.pone.0062383
  16. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the $2^{-\Delta\Delta{Ct}}$ method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262
  17. Marie Loh M, Liem N, Vaithilingam A, et al (2014). DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach. BMC Gastroenterol, 14, 55. https://doi.org/10.1186/1471-230X-14-55
  18. Mascaux C, Martin B, Verdebout JM, et al (2003). Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53. Eur Respir J, 21, 753-8. https://doi.org/10.1183/09031936.03.00090202
  19. Masood N, Malik FA, Kayani MA (2011). Expression of xenobiotic metabolizing genes in head and neck cancer tissues. Asian Pac J Cancer Prev, 12, 377-82.
  20. Maxwell A, McCudden CR, Wians F, et al (2009). Recent advances in the detection of prostate cancer using epigenetic markers in commonly collected laboratory samples. Lab Med, 40, 171-8. https://doi.org/10.1309/LMMY5RHJL9UD6RGS
  21. Moyer AM, Salavaggione OE, Wu TY, et al (2008). Glutathione S-transferase P1: gene sequence variation and functional genomic studies. Cancer Res, 68, 4791-5001. https://doi.org/10.1158/0008-5472.CAN-07-6724
  22. Prakash P Khandar M, Kumar M, et al (2013). Immunohistochemical detection of p16INK4a in Leukoplakia and Oral Squamous Cell Carcinoma. J Clin Diagn Res, 7, 2793-5.
  23. Ritchie KJ, Henderson CJ, Wang XJ, et al (2007). Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res, 67, 9248-57. https://doi.org/10.1158/0008-5472.CAN-07-1764
  24. Sargolzaei S, Farhadi S, Kazemi B, et al (2014). The correlation between p16 expression and INK4a locus mutation with grades and stages in oral squamous cell carcinoma. Indian J Pathol Microbiol, 57, 24-30. https://doi.org/10.4103/0377-4929.130877
  25. Sinha R, Hussain S, Mehrotra R, et al (2013). Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in indian population. PLoS ONE, 8, 60142. https://doi.org/10.1371/journal.pone.0060142
  26. Slonchak AM, Cwieduk A, Rzerzowska-Wolny J, et al (2009). Crosstalk between transcription factors in regulation of the human glutathione S-transferase P1 gene expression in Me45 melanoma cells. Biopolymers and Cell, 25, 210-7. https://doi.org/10.7124/bc.0007DE
  27. Sozzi G, Pastorino U, Moiraghi L, et al (1998). Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res, 58, 5032-7.
  28. Spivack SD, Hurteau GJ, Fasco MJ, et al (2003). Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res, 9, 6002-11.
  29. Spivack SD, Hurteau GJ, Jain R, et al (2004). Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal-cells. Cancer Res, 64, 6805-13. https://doi.org/10.1158/0008-5472.CAN-04-1771
  30. Stein CK, Glover TW, Palmer JL, et al (2002). Direct correlation between FRA3B expression and cigarette smoking. Gene Chromosomes Can, 34, 333-40. https://doi.org/10.1002/gcc.10061
  31. Subramaniam S, Thakur RK, Yadav VK, et al (2013). Lung cancer biomarkers: State of the art. J Carcinog, 12, 3. https://doi.org/10.4103/1477-3163.107958
  32. Sun N, Sun X, Chen B, et al (2010). MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol, 65, 437-46. https://doi.org/10.1007/s00280-009-1046-1
  33. Tseng JE, Kemp BL, Khuri FR, et al (1999). Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res, 59, 4798-03.
  34. Turella P, Pedersen JZ, Caccuri AM, et al (2003). Glutathione transferase superfamily behaves like storage proteins for dinitrosyl-diglutathionyl-iron complex in heterogeneous systems. J Biol Chem, 278, 42294-99. https://doi.org/10.1074/jbc.M305569200
  35. Xie K-J, He H-E, Sun A-J, et al (2014). Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy. Asian Pac J Cancer Prev, 15, 2591-6. https://doi.org/10.7314/APJCP.2014.15.6.2591
  36. Zhou C, Chen H, Han L, et al (2014). Screening of genes related to lung cancer caused by smoking with RNA-Seq. Eur Rev Med Pharmacol Sci, 18, 117-25.
  37. Zochbauer-Muller S, Fong KM, Maitra A, et al (2001). 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res, 61, 3581-5.
  38. Zochbauer-Muller S, Wistuba II, Minna JD, et al (2000). Fragile histidine triad (FHIT) gene abnormalities in lung cancer. Clin Lung Cancer, 2, 141-5. https://doi.org/10.3816/CLC.2000.n.027
  39. Zuo H, Chan GPW, Zhu J, et al (2013). Activation statedependent interaction between $G\alpha{q}$ subunits and the Fhit tumor suppressor. Cell Commun Signal, 11, 59-75. https://doi.org/10.1186/1478-811X-11-59

피인용 문헌

  1. Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer vol.10, pp.4, 2015, https://doi.org/10.3892/etm.2015.2666
  2. Analysis of FHIT Gene Methylation in Egyptian Breast Cancer Women: Association with Clinicopathological Features vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1235
  3. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.4071
  4. DNA methylation profile and expression of surfactant protein A2 gene in lung cancer vol.41, pp.2, 2015, https://doi.org/10.3109/01902148.2014.976298
  5. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma vol.48, pp.1, 2016, https://doi.org/10.3892/ijo.2015.3251
  6. Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications vol.8, pp.8, 2016, https://doi.org/10.2217/epi.16.10
  7. Genes in tissue Biopsy and Matched Serum of Advanced-Stage Lung Cancer Patients vol.35, pp.6, 2017, https://doi.org/10.1080/07357907.2017.1309547
  8. Establishment of Two Data Mining Models of Lung Cancer Screening Based on Three Gene Promoter Methylations Combined with Telomere Damage vol.32, pp.1, 2017, https://doi.org/10.5301/jbm.5000232